Search Results
Showing 10 from 107 results
Research Development
Teva s Global R D organization is devoted to the development of new medicines devices and combination products that provide meaningful therapeutic benefit
Introducing Teva USA s 2022 HBA Rising Stars Luminary
For the past seven years we have collaborated with the Healthcare Business Women s Association HBA to help support and advance women in our organization through its Rising Star and Luminary Program
What are the 3 biggest elements shaping clinical development today
From the increased incorporation of patient perspectives to the growing rise of technology in research Teva s Head of Global Early Clinical Development Eran Harary outlines the trends he s watching